StratifiCare™ Pte. Ltd.

StratifiCare™ Pte. Ltd. is a Singapore-based startup focused on developing and manufacturing IVD (In-Vitro Diagnostics) assay solutions for personalized medicine. With over 50 years of cumulative experience in Biomedical R&D and technology commercialization, StratifiCare™ aims to empower personalized medicine by creating high-quality diagnostics for the clinical market. The company's solutions are developed in accordance with the ISO13485 international quality standard, reflecting their commitment to quality and innovation in the biotechnology, healthcare, information technology, and manufacturing industries. Founded in 2015, StratifiCare™ is dedicated to creating value by supporting physicians in making informed decisions for individual patient care and improving clinical and socioeconomic outcomes. The company recently received a SGD1.00M seed round investment on 07 September 2021, with funding from ADB Ventures, Jeffrey Tiong, and Quek Siu Rui. This investment signifies a vote of confidence in StratifiCare™'s mission of developing innovative in vitro diagnostic solutions and their potential for growth and impact in the healthcare industry.